Cargando…

Vaccine Delivery Methods into the Future

Several modes of vaccine delivery have been developed in the last 25 years, which induce strong immune responses in pre-clinical models and in human clinical trials. Some modes of delivery include, adjuvants (aluminum hydroxide, Ribi formulation, QS21), liposomes, nanoparticles, virus like particles...

Descripción completa

Detalles Bibliográficos
Autor principal: Apostolopoulos, Vasso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931626/
https://www.ncbi.nlm.nih.gov/pubmed/27043641
http://dx.doi.org/10.3390/vaccines4020009
_version_ 1782440932514201600
author Apostolopoulos, Vasso
author_facet Apostolopoulos, Vasso
author_sort Apostolopoulos, Vasso
collection PubMed
description Several modes of vaccine delivery have been developed in the last 25 years, which induce strong immune responses in pre-clinical models and in human clinical trials. Some modes of delivery include, adjuvants (aluminum hydroxide, Ribi formulation, QS21), liposomes, nanoparticles, virus like particles, immunostimulatory complexes (ISCOMs), dendrimers, viral vectors, DNA delivery via gene gun, electroporation or Biojector 2000, cell penetrating peptides, dendritic cell receptor targeting, toll-like receptors, chemokine receptors and bacterial toxins. There is an enormous amount of information and vaccine delivery methods available for guiding vaccine and immunotherapeutics development against diseases.
format Online
Article
Text
id pubmed-4931626
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49316262016-07-08 Vaccine Delivery Methods into the Future Apostolopoulos, Vasso Vaccines (Basel) Editorial Several modes of vaccine delivery have been developed in the last 25 years, which induce strong immune responses in pre-clinical models and in human clinical trials. Some modes of delivery include, adjuvants (aluminum hydroxide, Ribi formulation, QS21), liposomes, nanoparticles, virus like particles, immunostimulatory complexes (ISCOMs), dendrimers, viral vectors, DNA delivery via gene gun, electroporation or Biojector 2000, cell penetrating peptides, dendritic cell receptor targeting, toll-like receptors, chemokine receptors and bacterial toxins. There is an enormous amount of information and vaccine delivery methods available for guiding vaccine and immunotherapeutics development against diseases. MDPI 2016-03-28 /pmc/articles/PMC4931626/ /pubmed/27043641 http://dx.doi.org/10.3390/vaccines4020009 Text en © 2016 by the author; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Apostolopoulos, Vasso
Vaccine Delivery Methods into the Future
title Vaccine Delivery Methods into the Future
title_full Vaccine Delivery Methods into the Future
title_fullStr Vaccine Delivery Methods into the Future
title_full_unstemmed Vaccine Delivery Methods into the Future
title_short Vaccine Delivery Methods into the Future
title_sort vaccine delivery methods into the future
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931626/
https://www.ncbi.nlm.nih.gov/pubmed/27043641
http://dx.doi.org/10.3390/vaccines4020009
work_keys_str_mv AT apostolopoulosvasso vaccinedeliverymethodsintothefuture